Hepatocellular Carcinoma Arising in a Non-cirrhotic Liver with Secondary Hemochromatosis

A 70-year-old man was admitted for treatment of a single liver nodule that was detected by contrast-enhanced computed tomography. Twenty years earlier, the patient had been diagnosed with myelodysplastic syndrome-refractory anemia and secondary hemochromatosis but had not received erythrocyte transf...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamauchi, Ryo, Takata, Kazuhide, Shinagawa, Yoshinobu, Tanaka, Takashi, Fukuda, Hiromi, Fukuda, Sho, Kunimoto, Hideo, Umeda, Kaoru, Morihara, Daisuke, Yokoyama, Keiji, Takeyama, Yasuaki, Irie, Makoto, Shakado, Satoshi, Mizoguchi, Mikirou, Hisano, Satoshi, Yoshimitsu, Kengo, Sakisaka, Shotaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443541/
https://www.ncbi.nlm.nih.gov/pubmed/30449774
http://dx.doi.org/10.2169/internalmedicine.0973-18
Descripción
Sumario:A 70-year-old man was admitted for treatment of a single liver nodule that was detected by contrast-enhanced computed tomography. Twenty years earlier, the patient had been diagnosed with myelodysplastic syndrome-refractory anemia and secondary hemochromatosis but had not received erythrocyte transfusions. The current histological, computed tomography, and magnetic resonance imaging findings revealed hepatocellular carcinoma (HCC) and non-cirrhotic liver hemochromatosis. The liver tumor was treated using radiofrequency ablation therapy. Secondary hemochromatosis may be a risk factor for HCC, even if the liver is not cirrhotic. In such cases, additional surveillance may be required to detect the development of HCC.

Ejemplares similares